ArticlePediatric radiology2026
Novel postoperative intrahepatic portal venous system classification for prediction of Rex shunt outcome in children with cavernous transformation of the portal vein.
Article in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies exploring preoperative intrahepatic portal venous system to evaluate Rex shunt efficacy in pediatric cavernous transformation of the portal vein have yielded controversial results.
objectiveTo develop a novel postoperative intrahepatic portal venous system classification to predict long-term outcomes of Rex shunt in children with cavernous transformation of the portal vein. MATERIALS AND
methodsFrom October 2014 to February 2024, children with cavernous transformation of the portal vein who underwent Rex shunt were retrospectively analyzed. One week after Rex shunt, intrahepatic portal venous system were classified into types A-C using ultrasound based on the patency of the connection between the Rex vein and the right portal vein. These types were further subdivided into subtypes based on the Rex vein inner diameter. We compared spleen length, spleen thickness, and esophageal variceal grading before and one year after Rex shunt across these types, as well as the incidence of vascular complications one year after Rex shunt.
resultsThe study included 160 children: 129 type A (124 type A1, 5 type A2), 25 type B (17 type B1, 8 B2), 6 type C1, with subtypes distinguished by an Rex vein inner diameter ≤ 4 mm. Type A exhibited superior outcomes compared to types B and C, which had comparable results. Type A1 demonstrated the most significant benefits, with fewer complications and improved variceal grading, although splenic size reduction was similar to that of type B1. Type B1 outperformed type B2 in terms of complications, variceal grading, and splenic measurements, and surpassed type A2 in splenic length reduction and type C1 in variceal grading and splenic thickness reduction.
conclusionsThe novel one-week postoperative intrahepatic portal venous system is effective to predict one-year postoperative outcomes of Rex shunt.
Indexed as
Identifiers
41591434What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.